Jennifer K. Simpson
Exec. VP, Global Marketing, Delcath Systems, Inc.
Companies
- Panbela Therapeutics, Inc.Board member Jul 17, 2020 to Oct 3, 20241
- Panbela Therapeutics, Inc.Chief executive officer Jul 17, 2020 to Oct 3, 20241
- Panbela Therapeutics, Inc.President Jul 17, 2020 to Oct 3, 20241
- CytRxBoard member Aug 11, 2021 to Jan 29, 20242
- EAGLE PHARMACEUTICALS, INC.Board member Sep 5, 2019 to Mar 9, 20233
- Delcath Systems, Inc.Board member Jul 26, 2019 to May 8, 20204
- Delcath Systems, Inc.President Jun 12, 2015 to May 8, 20205
- Delcath Systems, Inc.Chief executive officer Nov 18, 2013 to May 8, 20206
- Delcath Systems, Inc.Exec. VP, Global Marketing Mar 26, 2012 to Mar 13, 20137
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CytRx CYTR25,000 shares8Dec 15, 2021
- Panbela Therapeutics, Inc.7,868 shares9Jan 30, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 30, 2023Bought 4,444 shares of Panbela Therapeutics, Inc.9
- Dec 15, 2021Granted 25,000 shares of CytRx8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCytRx, Board member
- 3
- 4SEC EDGARDelcath Systems, Inc., Board member
- 5SEC EDGARDelcath Systems, Inc., President
- 6
- 7
- 8
- 9